COHN Stock Chart & Stats
$2391.38
$0.00(0.00%)
At close: 4:00 PM EDT
$2391.38
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$2,391.38 - $3,238.00
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
$95.52B
Enterprise Value$17.14K
Total Cash (Recent Filing)$187.10M
Total Debt (Recent Filing)$427.80M
Price to Earnings (P/E)22.7
Beta-0.02
Next Earnings
Aug 18, 2026EPS Estimate
20.56Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)5.28
Shares Outstanding65,398,920
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio5.50
Price to Book (P/B)10.08
Price to Sales (P/S)8.39
P/FCF Ratio112.21
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$1,421.40Price Target Upside-40.56% Downside
Rating ConsensusHold
Number of Analyst Covering7
EPS Forecast (FY)64
Revenue Forecast (FY)$29.35B
Bulls Say, Bears Say
Bulls Say
High Margins & ProfitabilitySustained high gross and operating margins reflect differentiated, high-value implant products and efficient manufacturing. Durable margin levels support reinvestment in R&D, capacity and aftermarket services, underpinning long-term return generation and competitive positioning.
Conservative Balance SheetVery low leverage and strong ROE provide financial flexibility for R&D, capex and bolt-on investments without stressing solvency. A conservative capital structure reduces refinancing risk and supports multi-year strategic programs and capacity expansion.
Recurring Aftermarket & Nexa AdoptionRapid Nexa adoption and subsequent unit uplifts point to stronger device replacement and upgrade cycles. Combined with services growth, this reinforces a recurring aftermarket revenue stream that stabilizes long-term cash flow and raises lifetime customer value.
Bears Say
Weaker Free Cash FlowA near-50% drop in free cash flow growth reduces near-term financial flexibility for buybacks, special investments or cushioning operating cycles. Persistent FCF weakness could constrain capital allocation and increase reliance on working capital or borrowing for strategic programs.
Gross Margin Compression & Launch MixMargin pressure from product launch costs and lower-margin regional mix can persist through ramp phases. If new-platform COGS and manufacturing ramp inefficiencies remain elevated, structural margin recovery may be slow and earnings power could be eroded.
Material FX Exposure And Partial HedgingSignificant currency sensitivity with only partial hedging exposes reported profits to AUD moves. Over several quarters this can introduce earnings volatility, complicate planning for R&D/capex and reduce the predictability of free cash flow for strategic investments.
Cochlear News
COHN FAQ
What was Cochlear Limited’s price range in the past 12 months?
Cochlear Limited lowest stock price was $2391.38 and its highest was $3238.00 in the past 12 months.
What is Cochlear Limited’s market cap?
Cochlear Limited’s market cap is $95.52B.
When is Cochlear Limited’s upcoming earnings report date?
Cochlear Limited’s upcoming earnings report date is Aug 18, 2026 which is in 11 days.
How were Cochlear Limited’s earnings last quarter?
Cochlear Limited released its earnings results on Feb 12, 2026. The company reported $36.251 earnings per share for the quarter, missing the consensus estimate of $38.331 by -$2.08.
Is Cochlear Limited overvalued?
According to Wall Street analysts Cochlear Limited’s price is currently Overvalued.
Does Cochlear Limited pay dividends?
Cochlear Limited does not currently pay dividends.
What is Cochlear Limited’s EPS estimate?
Cochlear Limited’s EPS estimate is 20.56.
How many shares outstanding does Cochlear Limited have?
Cochlear Limited has 65,398,920 shares outstanding.
What happened to Cochlear Limited’s price movement after its last earnings report?
Cochlear Limited reported an EPS of $36.251 in its last earnings report, missing expectations of $38.331. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Cochlear Limited?
Currently, no hedge funds are holding shares in MX:COHN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cochlear Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$1,421.40 (-40.56% Downside)
$1,421.40 (-40.56% Downside)
Blogger Sentiment
Bullish
MX:COHN Sentiment 84%
Sector Average ―
Sector Average ―
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-55.22%
12-Months-Change
Fundamentals
Return on Equity
2.36%
Trailing 12-Months
Asset Growth
8.00%
Trailing 12-Months
Company Description
Cochlear Limited
Globally, Cochlear Limited specializes in the development and provision of implantable auditory solutions for both children and adults. The company's diverse offerings include advanced cochlear implant systems, upgrades for sound processors, bone conduction devices, and a wide array of accessories and other related items. Established in 1981, its global operations are directed from its headquarters in Sydney, Australia.
COHN Stock 12 Month Forecast
Average Price Target
$1,421.40
▼(-40.56% Downside)